Cogent Biosciences Inc (COGT)

R&D Expense Growth

-6.04%

Quarterly · Period ending:

COGT logo

COGT R&D Expense Growth

Latest reported-6.04%
COGT Quarterly R&D Growth (QoQ) (0.00% → -6.04%)
High-resolution chart · PNG

COGT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-6.0426%
1.3216%
7.8172%
13.0115%
-3.1462%
1.5859%
-2.4664%
17.1658%
3.0149%
8.1816%
-2.8089%
28.9573%
7.8611%
-1.9161%
22.7352%
1.5503%
15.7401%
24.1591%
38.6268%
19.4543%
50.834%
34.463%
-88.2342%
912.1466%
-45.9992%
-8.2673%
0.1838%
-2.6561%
-14.3997%
15.216%
5.0039%
12.3384%
12.0855%
7.6699%
-7.5211%
14.5078%
2.7186%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.